Mylan (MYL) Misses Q1 EPS by 1c

Mylan (NASDAQ: MYL) reported Q1 EPS of $0.96, $0.01 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $2.68 billion versus the consensus estimate of $2.75 billion.

• Reaffirms 2018 Guidance

For earnings history and earnings-related data on Mylan (MYL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c